AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets

AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets

РMulti-year collaboration to identify up to 10 novel target-antibody pairs leveraging Immunome’s Discovery Engine

– Immunome to receive $30M upfront payment with potential for further platform access and option payments as well as development, commercial, and sales-based milestones, and tiered royalties

See more here

Comments are closed.